220 related articles for article (PubMed ID: 27806050)
1. Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis.
Sharma A; Sharma M; Yogavel M; Sharma A
PLoS Negl Trop Dis; 2016 Nov; 10(11):e0005084. PubMed ID: 27806050
[TBL] [Abstract][Full Text] [Related]
2. Structural analyses of the malaria parasite aminoacyl-tRNA synthetases provide new avenues for antimalarial drug discovery.
Chhibber-Goel J; Yogavel M; Sharma A
Protein Sci; 2021 Sep; 30(9):1793-1803. PubMed ID: 34184352
[TBL] [Abstract][Full Text] [Related]
3. Genomic analyses of aminoacyl tRNA synthetases from human-infecting helminths.
Goel P; Parvez S; Sharma A
BMC Genomics; 2019 May; 20(1):333. PubMed ID: 31046663
[TBL] [Abstract][Full Text] [Related]
4. Drugging the schistosome zinc-dependent HDACs: current progress and future perspectives.
Marek M; Oliveira G; Pierce RJ; Jung M; Sippl W; Romier C
Future Med Chem; 2015; 7(6):783-800. PubMed ID: 25996070
[TBL] [Abstract][Full Text] [Related]
5. Novel Non-Peptide Inhibitors against SmCL1 of Schistosoma mansoni: In Silico Elucidation, Implications and Evaluation via Knowledge Based Drug Discovery.
Zafar A; Ahmad S; Rizvi A; Ahmad M
PLoS One; 2015; 10(5):e0123996. PubMed ID: 25933436
[TBL] [Abstract][Full Text] [Related]
6. Identification of novel multi-stage histone deacetylase (HDAC) inhibitors that impair Schistosoma mansoni viability and egg production.
Guidi A; Saccoccia F; Gennari N; Gimmelli R; Nizi E; Lalli C; Paonessa G; Papoff G; Bresciani A; Ruberti G
Parasit Vectors; 2018 Dec; 11(1):668. PubMed ID: 30587243
[TBL] [Abstract][Full Text] [Related]
7. Schistosome sirtuins as drug targets.
Lancelot J; Cabezas-Cruz A; Caby S; Marek M; Schultz J; Romier C; Sippl W; Jung M; Pierce RJ
Future Med Chem; 2015; 7(6):765-82. PubMed ID: 25996069
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the function and inhibition of dihydroorotate dehydrogenase from Schistosoma mansoni.
de Mori RM; Aleixo MAA; Zapata LCC; Calil FA; Emery FS; Nonato MC
FEBS J; 2021 Feb; 288(3):930-944. PubMed ID: 32428996
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme.
Jacques SA; Kuhn I; Koniev O; Schuber F; Lund FE; Wagner A; Muller-Steffner H; Kellenberger E
J Med Chem; 2015 Apr; 58(8):3582-92. PubMed ID: 25803425
[TBL] [Abstract][Full Text] [Related]
10. Large-scale RNAi screening uncovers therapeutic targets in the parasite
Wang J; Paz C; Padalino G; Coghlan A; Lu Z; Gradinaru I; Collins JNR; Berriman M; Hoffmann KF; Collins JJ
Science; 2020 Sep; 369(6511):1649-1653. PubMed ID: 32973031
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based methods for the discovery of inhibitors modulating lysyl-tRNA synthetase and laminin receptor interaction.
Cho HY; Kim S; Jeon YH
Methods; 2017 Jan; 113():56-63. PubMed ID: 27789335
[TBL] [Abstract][Full Text] [Related]
12. Genetic Validation of
Chadha S; Mallampudi NA; Mohapatra DK; Madhubala R
mSphere; 2017; 2(4):. PubMed ID: 28875178
[No Abstract] [Full Text] [Related]
13. Structural features and development of an assay platform of the parasite target deoxyhypusine synthase of Brugia malayi and Leishmania major.
Silva SF; Klippel AH; Ramos PZ; Santiago ADS; Valentini SR; Bengtson MH; Massirer KB; Bilsland E; Couñago RM; Zanelli CF
PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008762. PubMed ID: 33044977
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel modulators of a schistosome transient receptor potential channel targeted by praziquantel.
Chulkov EG; Smith E; Rohr CM; Yahya NA; Park SK; Scampavia L; Spicer TP; Marchant JS
PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009898. PubMed ID: 34731172
[TBL] [Abstract][Full Text] [Related]
15. Side chain rotameric changes and backbone dynamics enable specific cladosporin binding in Plasmodium falciparum lysyl-tRNA synthetase.
Chhibber-Goel J; Sharma A
Proteins; 2019 Sep; 87(9):730-737. PubMed ID: 31017332
[TBL] [Abstract][Full Text] [Related]
16. Molecular basis for the antiparasitic activity of a mercaptoacetamide derivative that inhibits histone deacetylase 8 (HDAC8) from the human pathogen schistosoma mansoni.
Stolfa DA; Marek M; Lancelot J; Hauser AT; Walter A; Leproult E; Melesina J; Rumpf T; Wurtz JM; Cavarelli J; Sippl W; Pierce RJ; Romier C; Jung M
J Mol Biol; 2014 Oct; 426(20):3442-53. PubMed ID: 24657767
[TBL] [Abstract][Full Text] [Related]
17. Characterization of potential drug targets farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase in Schistosoma mansoni.
Ziniel PD; Desai J; Cass CL; Gatto C; Oldfield E; Williams DL
Antimicrob Agents Chemother; 2013 Dec; 57(12):5969-76. PubMed ID: 24041901
[TBL] [Abstract][Full Text] [Related]
18. An Abies procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni.
Whiteland HL; Chakroborty A; Forde-Thomas JE; Crusco A; Cookson A; Hollinshead J; Fenn CA; Bartholomew B; Holdsworth PA; Fisher M; Nash RJ; Hoffmann KF
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):465-474. PubMed ID: 30399512
[TBL] [Abstract][Full Text] [Related]
19. Discovery of novel potent migrastatic Thiazolo[5,4-b]pyridines targeting Lysyl-tRNA synthetase (KRS) for treatment of Cancer metastasis.
Lee S; Kwon NH; Seo B; Lee JY; Cho HY; Kim K; Kim HS; Jung K; Jeon YH; Kim S; Suh YG
Eur J Med Chem; 2021 Jun; 218():113405. PubMed ID: 33831781
[TBL] [Abstract][Full Text] [Related]
20. Atomic Resolution Analyses of Isocoumarin Derivatives for Inhibition of Lysyl-tRNA Synthetase.
Zhou J; Zheng L; Hei Z; Li W; Wang J; Yu B; Fang P
ACS Chem Biol; 2020 Apr; 15(4):1016-1025. PubMed ID: 32195573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
